Canadian Blood Services Clinical Trials
Sponsors / Canadian Blood Services
ClinicalTrials.gov lists 21 trials for which Canadian Blood Services is named as lead sponsor. The portfolio currently includes 3 recruiting studies, 0 active non-recruiting studies, and 9 completed studies. 2 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 20,886 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
21
Total Trials
3
Recruiting
0
Other Active
9
Completed
2
Terminated / Withdrawn
20,886
Total Enrollment
Termination reasons: Recruitment50% · Efficacy50%
Recent Terminations
- COVID-19"Study was terminated after the planned interim analysis as the pre-defined futility threshold was met"
- Leukemia"Poor recruitment"
Active Trials (0 total)
- Bleeding PHASE2NCT06147531
- Acute Kidney Injury PHASE4NCT04705896
- Trauma NANCT06495294